Emicizumab for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with Haemophilia A (congenital Factor VIII deficiency) with or without Factor VIII inhibitors
Lambert R, Tivey D
Record ID 32018004581
English
Details
Project Status:
Completed
Year Published:
2018
URL for published report:
http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1510-public
Requestor:
Commonwealth of Australia, Canberra, ACT.
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Hemophilia A
- Factor VIII
- Bleeding Time
- Hemorrhage
- Antibodies, Bispecific
- Hemostatics
Contact
Organisation Name:
Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
Contact Address:
ASERNIP-S 24 King William Street, Kent Town SA 5067 Australia Tel: +61 8 8219 0900
Contact Name:
racs.asernip@surgeons.org
Contact Email:
racs.asernip@surgeons.org
Copyright:
Australian Safety and Efficacy Register of New Interventional Procedures - Surgical
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.